Economics of Cognitive Decline and Dementia (ECID)

29 Jun 2017

Professor Brenda Gannon has organised a special session on Economics of Cognitive Decline and Dementia (ECID) for the International Health Economics Association, World Congress, in Boston, US, July 8-11th, 2017.

The session will involve colleagues from Universities in Australia (UWA, Curtin), UK (Sheffield), and US(Washington, Michigan). Professor Gannon is co-chair of the Methodology Panel on the Scientific Committee, and will also be involved in a Mentoring program at the conference.

Session Overview

This session will present new empirical studies and methodologies in the health economics of dementia and cognitive decline. It is now recognised that impaired cognitive status is a hallmark of dementia and recent research shows that cognitive decline may begin much earlier than expected, with onset often occurring at middle age Singh-Manoux and et al (2012). Given that the global cost of dementia stands at US604 billion, amounting to 1-2% of GDP in developed countries (Alzheimer (2012)), these impacts cannot be ignored any more in health care utilization models. Of major policy concern is any additional strain that cognitive decline may place on the health system. Provision of information on cognitive decline diagnosis of dementia is now encouraged to ensure people receive adequate treatment and to try and delay the onset of dementia. This is of concern to policy makers and health budget planners who are interested to know if such new diagnoses would increase demand for health care use. In addition, development of trials for new treatments for dementia and early onset are at the forefront of minds of industry. Agreement on data collection instruments is also vital to the success of critical health economics evaluation within randomized control trials. This is particularly important in the context of multi-centered trials across several international sites. This session will therefore tackle two aspects of economics of dementia and cognitive decline across Europe and the US, focusing on (1) health care utilization and (2) costs modelling.

The session will involve 4 papers:

  1. Gannon, (Queensland) Harris (Curtin) and Magnusson (UWA), Modelling multiple modes in health care utilization distributions: investigating the impact of cognitive impairment
  2. Lugo-Palacios (Manchester) and Gannon (Queensland), The combined effect of sensory and cognitive impairments on health care resource use in older Europeans
  3. Lindsay, Basu, Fishman Crane, Larson and Coe (University of Washington), The Incremental Costs of Dementia: Comparing Medicare FFS and Advantage
  4. Thokala, Praveen Dementia as a Comorbidity of Diabetes in Evaluating Interventions

Find out more